Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 480-340-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- June 17th to July 9th, 2008
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 008
- Report date:
- 2008
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- adopted April 24th, 2002
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- -
- EC Number:
- 480-340-8
- EC Name:
- -
- Cas Number:
- 156157-97-0
- Molecular formula:
- C12H30Cl2N2Na2O14
- IUPAC Name:
- Di(µ-2,2´,2´´-nitrilotris(ethanol)-diperchlorato)dinatrium
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA/Ca
- Remarks:
- CBA/CaOlaHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Netherlands, B.V. Postbus 6174, NL - 5960 AD Horst, The Netherlands.
- Females nulliparous and non-pregnant: yes.
- Age at study initiation: 8 - 12 weeks.
- Weight at study initiation: 18.8 - 23.6 g.
- Housing: single caging. Makrolon Type I, with wire mesh top with granulated soft wood bedding.
- Diet: pelleted standard diet, ad libitum.
- Water: tap water, ad libitum.
- Acclimatisation: at least 5 days prior to the start of dosing under test conditions after health examination. Only animals without any visible signs of illness were used for the study.
ENVIRONMENTAL CONDITIONS
- Temperature: 22 ± 3°C.
- Humidity: 30 - 70 %.
- Photoperiod: 12 hrs dark / 12 hrs light; artificial light 6.00 a.m. - 6.00 p.m.
Study design: in vivo (LLNA)
- Vehicle:
- other: ethanol:deionised water, 7+3
- Concentration:
- 10 %, 25 %, 50 %.
- No. of animals per dose:
- five animals per dose group.
- Details on study design:
- PRE-SCREEN TESTS:
- Compound solubility: the highest test item concentration which can be technically used was a 50 % solution in ethanol:deionised water (7+3).
- Dose selection test: to determine the highest non-irritant test concentration, a pre-test was performed in two animals. Two mice were treated with concentrations of 5, 10, 25 and 50 % on one ear each on three consecutive days. Clinical signs were recorded 24 ± 4 hours after each application.
- Rationale for dose selections: at the tested concentrations the animals did not show any signs of irritation or systemic toxicity. The top dose is the highest technically achievable concentration whilst avoiding systemic toxicity and excessive local irritation. No severe irritant effects were tolerated choosing the test concentrations.
TEST ITEM PREPARATION: the test item was placed into a volumetric falsk on a tared balance and the vehicle was quantitavely added. The preparations were made freshly before each dosing occasion. Concentrations were in terms of material as supplied.
TOPICAL APPLICATION: each test group of mice was treated by topical (epidermal) application to the dorsal surface of each ear lobe (left and right) with different test item concentrations of 10, 25, and 50 % (w/v) in ethanol:deionised water (7+3). The application volume, 25 μl, was spread over the entire dorsal surface ( ̴ 8 mm) of each ear lobe once daily for three consecutive days. A further group of mice was treated with an equivalent volume of the relevant vehicle alone (control animals).
ADMINISTRATION of 3H-METHYL THYMIDINE (3HTdR): five days after the first topical application, all mice were administered with 250 μl of 81.1 μCi/ml 3HTdR (corresponds to 20.3 μCi 3HTdR per mouse) by intravenous injection via the tail vein.
LYMPH NODES POOLED: approximately five hours after treatment with 3HTdR all mice were euthanised by intraperitoneal injection of Pentobarbital - Natrium. The draining lymph nodes were rapidly excised and pooled per group (10 nodes per group besides of the vehicle control group where only 8 nodes per group could be evaluated due to the death of animal).
PREPARATION OF CELL SUSPENSIONS: single cell suspensions (in phosphate buffered saline) of pooled lymph node cells were prepared by gentle mechanical disaggregation through stainless steel gauze (200 μm mesh size). After washing two times with phosphate buffered saline (approx. 10 ml) the lymph node cells were resuspended in 5 % trichloroacetic acid (approx. 3 ml) and incubated at approximately 4 °C for at least 18 hours for precipitation of macromolecules. The precipitates were then resuspended in 5 % trichloroacetic acid (1 ml) and transferred to plastic scintillation vials with 10 ml of ‘Ultima Gold’ scintillation liquid and thoroughly mixed.
DETERMINATION OF CELLULAR PROLIFERATION: the level of 3HTdR incorporation was then measured on a β-scintillation counter. Similarly, background 3HTdR levels were also measured in two 1 ml - aliquots of 5 % trichloroacetic acid. The β - scintillation counter expresses 3HTdR incorporation as the number of radioactive disintegrations per minute (DPM).
OBSERVATIONS: the animals were observed for mortality / viability once daily (week day) from experimental start to necropsy. Body weights were measured prior to the first application and prior to treatment with 3HTdR. Clinical signs (local / systemic) were observed once daily (week day). The treatment sites were observed carefully.
CRITERIA USED TO CONSIDER A POSITIVE RESPONSE:
- Criteria used to consider a positive response: a test item is regarded as a sensitiser in the LLNA if the following criteria are fulfilled: first, that exposure to at least one concentration of the test item resulted in an incorporation of 3HTdR at least 3-fold or greater than that recorded in control mice, as indicated by the stimulation index and second, that the data are compatible with a conventional dose response, although allowance must be made (especially at high topical concentrations) for either local toxicity or immunological suppression. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- The mean values and standard deviations were calculated for the body weights.
Results and discussion
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Value:
- 0.74
- Test group / Remarks:
- High dose group (50 %)
- Remarks on result:
- other: EC3 not determined.
- Parameter:
- SI
- Value:
- 0.85
- Test group / Remarks:
- Medium dose group (25 %)
- Remarks on result:
- other: EC3 not determined.
- Parameter:
- SI
- Value:
- 1.05
- Test group / Remarks:
- Low dose group (10 %)
- Remarks on result:
- other: EC3 not determined.
- Cellular proliferation data / Observations:
- DETAILS ON STIMULATION INDEX CALCULATION: the proliferative response of lymph node cells is expressed as the number of radioactive disintegrations per minute per lymph node (DPM/node) and as the ratio of 3HTdR incorporated into lymph node cells of test lymph nodes relative to that recorded for control lymph nodes (stimulation index). Before DPM/node values were determined, mean scintillation-background DPM was subtracted from test and control raw data.
EC3 CALCULATION: EC3 value (estimated concentration of test item required to produce a S.I. of 3) could not be calculated, since all S.I.´s are below 3.
OBSERVATIONS
- Mortality/viability: one animal from control group was found dead on the day of preparation.
- Clinical signs: no symptoms of local toxicity at the ears of the animals and no systemic findings were observed during the study period.
- Body weights: the body weight of the animals, recorded prior to the first application and prior to treatment with 3HTdR, was within the range commonly recorded for animals of this strain and age.
Any other information on results incl. tables
The results and the Stimulation Index (SI) for each tested group are presented in the table below.
Table: stimulation index per tested group.
Test item concentration % (w/v) |
Group | Measurement DPM |
Calculation | Result | ||
DPM-BG a) | number of lymph nodes |
DPM per lymph node b) |
S.I. | |||
- | BG I | 24 | - | - | - | - |
- | BG II | 23 | - | - | - | - |
- | control | 3243 | 3220 | 8 | 402.4 | |
10 | low dose | 4244 | 4221 | 10 | 422.1 | 1.05 |
25 | mid dose | 3462 | 3439 | 10 | 343.9 | 0.85 |
50 | high dose | 3003 | 2980 | 10 | 298 | 0.74 |
BG = background (1 ml 5 % trichloroacetic acid) in duplicate.
S.I. = stimulation index.
a) the mean value was taken from the figures BG I and BG II.
b) since the lymph noded of the animals of a dose group were pooled, DPM/node was determined by dividing the measured value by the number of lymph nodes pooled.
Positive Control results
Positive control substance was tested in February 2008 and its S.I at test concentration 10 % was found to be 1.84 whereas at concentration 25 % was found to be 4.87. The EC3 calculated was equal to 15.7 % (w/v).
Deviation from Study Plan
In the vehicle control group one animal was found dead on the day of preparation. Therefore, only 8 instead of 10 lymph nodes could be evaluated for this group. This deviation does not affect the validity of the study.
Applicant's summary and conclusion
- Interpretation of results:
- other: not classified as skin sensitiser according to the CLP Regulation (EC) No.1272/2008
- Conclusions:
- The substance is not a skin sensitiser.
- Executive summary:
The sensitising potential of the substance was assessed in the LLNA test according to the OECD Guideline 429. Groups of five female mice were treated daily for three consecutive days with the test item at concentrations of 10, 25, and 50 % (w/v) by topical application to the dorsum of each ear lobe. A control group was treated with the vehicle only. Five days after the first topical application the mice were injected intravenously with radio-labelled thymidine (3HTdR). Five hours after intravenous injection, the mice were sacrificed, the draining auricular lymph nodes excised and pooled per group. The proliferative capacity of pooled lymph node cells was determined by the incorporation of 3HTdR measured in a β- scintilltion counter.
The animals did not show any clinical signs during the course of the study and no cases of local irritation or test item-related mortality were observed. One animal of the vehicle control group (animal 1) was found dead on the day of preparation. In this study Stimulation Indices (S.I.) of 1.05, 0.85, and 0.74 were determined with the test item at concentrations of 10, 25, and 50 % respectively. The estimated concentration of test item required to produce a S.I. of 3 is referred to as the EC3 value. In this study the EC3 value could not be calculated, since none of the tested concentrations induced an S.I. greater than 3.
The substance is not a skin sensitiser under the tested conditions.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.